Monopar Therapeutics (MNPR) PT Raised to $142 at Raymond James
Tweet Send to a Friend
Raymond James analyst Chris Raymond raised the price target on Monopar Therapeutics (NASDAQ: MNPR) to $142.00 (from $80.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
